Herbst Group’s Pfizer PFE Stock Holding History

Herbst Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-24,633	Closed	-$709K	–	66
2023 Q4	$709K	Sell	24,633 -6,967	-22%	-$211K	0.45%	54
2023 Q3	$1.05M	Buy	31,600 +3,300	+12%	+$117K	0.75%	48
2023 Q2	$1.04M	Buy	+28,300	New	+$1.1M	0.72%	52

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Herbst Group's PFE Position: Q1 2024 in Review

Herbst Group sold out of Pfizer (PFE) in Q1 2024, closing a stake of 24,633 shares — an estimated $709K sold.

Herbst Group first reported a position in PFE in Q2 2023 and held it in 3 quarters. The position peaked at $1.05M in Q3 2023. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Herbst Group reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
Herbst Group sold 24,633 Pfizer shares in Q1 2024, an estimated $709K.
Herbst Group first reported a position in Pfizer in Q2 2023 and held it in 3 quarters.
Herbst Group's Pfizer position peaked at $1.05M in Q3 2023.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Herbst Group's 13F filing for Q1 2024, filed 22 Apr 2024.